Prolactin-secreting tumors: what's new?
- PMID: 17004854
- DOI: 10.1586/14737140.6.9s.S29
Prolactin-secreting tumors: what's new?
Abstract
Prolactinomas are a common cause of reproductive/sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history and physical examination, routine chemistries, a pregnancy test and a thyroid-stimulating hormone, imaging with magnetic resonance imaging or computed tomography will delineate the size and extent of the tumor. Medical therapy with cabergoline or bromocriptine is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety experience and is preferred by some clinicians. However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective or not tolerated.
Similar articles
-
Disorders of prolactin secretion.Endocrinol Metab Clin North Am. 2001 Sep;30(3):585-610. doi: 10.1016/s0889-8529(05)70203-6. Endocrinol Metab Clin North Am. 2001. PMID: 11571932 Review.
-
Medical treatment of prolactinomas.Endocrinol Metab Clin North Am. 1999 Mar;28(1):143-69, vii. doi: 10.1016/s0889-8529(05)70061-x. Endocrinol Metab Clin North Am. 1999. PMID: 10207689 Review.
-
Medical management of prolactin-secreting pituitary adenomas.Pituitary. 2002;5(2):55-65. doi: 10.1023/a:1022375429083. Pituitary. 2002. PMID: 12675502 Review.
-
Diagnosis and management of galactorrhea.Am Fam Physician. 2004 Aug 1;70(3):543-50. Am Fam Physician. 2004. PMID: 15317441
-
Update on prolactinomas. Part 2: Treatment and management strategies.J Clin Neurosci. 2015 Oct;22(10):1568-74. doi: 10.1016/j.jocn.2015.03.059. Epub 2015 Aug 1. J Clin Neurosci. 2015. PMID: 26243714 Review.
Cited by
-
Clinical characteristics and surgical outcome of prolactinoma in patients under 14 years old.Medicine (Baltimore). 2019 Feb;98(6):e14380. doi: 10.1097/MD.0000000000014380. Medicine (Baltimore). 2019. PMID: 30732174 Free PMC article.
-
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.Cancer Res Treat. 2017 Apr;49(2):358-373. doi: 10.4143/crt.2016.017. Epub 2016 Jul 28. Cancer Res Treat. 2017. PMID: 27488872 Free PMC article.
-
Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience.Brain Tumor Res Treat. 2013 Oct;1(2):71-7. doi: 10.14791/btrt.2013.1.2.71. Epub 2013 Oct 31. Brain Tumor Res Treat. 2013. PMID: 24904895 Free PMC article.
-
Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.J Neurooncol. 2011 Aug;104(1):195-204. doi: 10.1007/s11060-010-0459-3. Epub 2010 Nov 24. J Neurooncol. 2011. PMID: 21107645
-
Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis.Cancer Cell Int. 2007 Mar 2;7:1. doi: 10.1186/1475-2867-7-1. Cancer Cell Int. 2007. PMID: 17331262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical